Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes
Clifford J Bailey
, Peter R Flatt
College of Health and Life Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Enteroendocrine Cells
85%
Type 2 Diabetes Mellitus
45%
Obesity
41%
gastric inhibitory polypeptide receptor
40%
Peptides
38%
Glucose
37%
Incretins
31%
Nutrients
30%
LY3298176
29%
Glucagon-Like Peptide 1
28%
Body Weight
17%
Hormones
16%
Glucagon-Like Peptide-1 Receptor
15%
Bariatrics
15%
Duodenum
12%
Digestion
10%
Hyperglycemia
10%
Intestines
10%
Blood Glucose
9%
Therapeutics
9%
Mucous Membrane
9%
Clinical Studies
8%
Weights and Measures
7%
Chemistry
Insulinotropic
100%
Glucagon-Like Peptide 1
56%
Polypeptide
49%
Nutrient
38%
Hormone
23%
Glycemic
18%
Peptide
13%
Weight
12%
Agonist
11%
Glucose
8%